Bob Li/LinkedIn
Jun 12, 2025, 11:19
Bob Li Visited Jules Bordet Institute and Discussed Clinical Trial Access with Oncology Leaders
Bob Li, SVP Global Head of Medical Affairs, Oncology at AstraZeneca, shared a post on LinkedIn:
“Back in Europe this week for a MARS field visit to the Jules Bordet Institute in Brussels, an internationally-acclaimed cancer center that has pioneered molecular oncology and targeted cancer therapies.
It was great for our cross-functional team to catch up with the President of the Belgian Society of Medical Oncology, Professor Evandro de Azambuja and Dr Elisa Agostinetto for some truly energizing conversations about reinvigorating clinical trials and innovation across Europe.
We really dug into how innovation and decentralization can help us embed greater health equity into our work, and how partnerships to expand community access to clinical trials are moving forward our vision to transform cancer care. Thanks to our team in Belgium for facilitating such a great conversation MARS style!”
More posts featuring the Jules Bordet Institute on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 3, 2025, 10:55
Jul 3, 2025, 10:25
Jul 3, 2025, 10:24
Jul 3, 2025, 10:16
Jul 3, 2025, 10:15
Jul 3, 2025, 10:04